from: Boshoff et al (2004). The transcriptional responses of Mycobacterium tuberculosis to inhibitors of metabolism. J Biol Chem.

Gene Expression Profile for Rv0836c/-

LFCtreatmentdescriptionclass of inhibitor

0.431

Amikacinug/mL Amikacintranslation

0.702

Cap5-10ug/mL Capreomycintranslation

0.615

Rox10-50 ug/mL Roxithromycintranslation

0.017

SM2-5 ug/mL Streptomycintranslation

1.356

Tet5-10 ug/mL Tetracyclinetranslation

0.394

Rif0.2-5ug/mL Rifampicintranscription

0.595

Rifp0.1-0.5ug/mL Rifapentinetranscription

0.638

Min_med__succinate_Minimal medium with succinate as sole carbon source as compared to growth in 7H9/ADC/Tween/glycerolstarvation

-0.042

CCCP10-50 uM Carbonyl cyanide 3-chlorophenylhydrazonerespiration

0.892

CPZ10-50 ug/mL Chlorpromazinerespiration

0.418

Clofazimine10-13 ug/mL Clofaziminerespiration

0.837

Clotrimazole10-24 ug/mL Clotrimazole (azole drug)respiration

0.000

DCCD20-100 uM Dicyclohexylcarbodiimiderespiration

1.239

DNP"0.5-2.5 mM 2,4-Dinitrophenol"respiration

-0.013

DTT"1-2 mM 1,4-Dithio-DL-threitol"respiration

1.530

Econazole10-24 ug/mL Econazole (azole drug)respiration

0.625

GSNO_CFZ0.1 mM S-Nitrosoglutathione + 5 ug/mL Clofaziminerespiration

0.108

GSNO_CPZ0.1 mM S-Nitrosoglutathione + 20-25 ug/mL Chlorpromazinerespiration

0.655

GSNO_KCN0.1mM S-Nitrosoglutathione + 5ug/mL potassium cyaniderespiration

0.086

GSNO_menadione0.1 mM S-Nitrosoglutathione + 6-10 ug/mL menadionerespiration

-0.021

KCN5-20 ug/mL Potassium cyaniderespiration

0.000

NaN30.2-2 mM Sodium aziderespiration

0.223

Nigericin50 uM Nigericinrespiration

0.656

TRC10-150 ug/mL Triclosanrespiration

0.590

TRZ10-25 ug/mL Thioridazinerespiration

0.909

Valinomycin0.5-10 uM Valinomycinrespiration

0.000

ZnSO42 mM ZnSO4respiration

0.219

menadione6-10 ug/mL Menadionerespiration

0.020

Ascididemin_Nat_prod4-9 ug/mL Organic extract of Eudistoma amplumironLimitation

-0.753

Deferoxamine150-250 uM Deferoxamine mesylateironLimitation

-0.397

Dipyridyl"100-200 uM 2,2'-Bipyridyl"ironLimitation

0.737

GSNO0.02-0.1mM S-NitrosoglutathionedosRassociated

-0.705

NRP_1Non-replicating persistence stage 1dosRassociated

0.184

Amp0.2mg/mL AmpicillincellWall

0.607

Cephalexin20-100 ug/mL CephalexincellWall

-0.047

Cerulenin0.32-5 ug/mL CerulenincellWall

-0.062

DIPED5-100 ug/mL DiisopropylethylenediaminecellWall

0.703

EMB10-20 ug/mL EthambutolcellWall

0.193

Eta12-40 ug/mL EthionamidecellWall

0.302

INH0.2-0.4 ug/mL IsoniazidcellWall

0.392

TLM0.1-0.2 mg/mL ThiolactomycincellWall

1.103

PalmitateMinimal medium with palmitate as sole C-source as compared to minimal medium with glucose as sole CsourcecarbonSource

1.192

SuccinateMinimal medium with succinate as sole C-source as compared to minimal medium with glucose as sole CsourcecarbonSource

-0.342

BZA0.12 mg/mL BenzamidearomaticAmides

-0.705

Nam0.12 - 1.2 mg/mL NicotinamidearomaticAmides

-0.537

PZA0.12-1.2 mg/mL PyrazinamidearomaticAmides

-0.167

H2O24 mM hydrogen peroxideDNAdamaging

0.442

Levo10 ug/mL LevofloxacinDNAdamaging

-1.140

Mtm0.1-0.2 ug/mL Mitomycin CDNAdamaging

1.657

Novobiocin10 ug/mL NovobiocinDNAdamaging

0.368

Oflox5-10 ug/mL OfloxacinDNAdamaging

-1.766

UVUV-irradiationDNAdamaging

0.678

ARP41-4 ug/mL Antitubercular compound ARP4?

0.433

Antimycin12.5-50 ug/mL Antimycin A?

-0.128

DTNB"1-2 mM 5,5'-Dithiobis(2-nitrobenzoic acid)"?

-0.178

PA_110-50 ug/mL Antitubercular compound PA-1?

0.237

PA_2110-50 ug/mL Antitubercular compound PA-21?

0.903

PA8240.2-2 ug/mL PA-824?

-0.502

Procept_677620-30 ug/mL Antitubercular compound Procept 6776?

-0.106

Procept_67785-40 ug/mL Antitubercular compound Procept 6778?

0.063

Verapamil50 uM Verapamil?

-0.027

mercaptoethanol2 mM 2-Mercaptoethanol?

0.653

methoxatin10-20 ug/mL Methoxatin?